Phase 4 Type 2 Diabetes Trial, Recruiting NCT05365438 Sponsor: Seoul National University Bundang Hospital Condition: Type 2 Diabetes
Back to Type 2 Diabetes

Phase 4 Type 2 Diabetes Trial, Recruiting

NCT05365438
Recruiting Phase 4

voxsanity.com.au · Eligibility summary from public government registries · 18 August 2026 · not medical advice

Who may and may not be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who may be able to join

  • People who have type 2 diabetes that is being treated, with blood sugar control (HbA1c) measured between 6.0% and 10.0% at the screening visit.
  • People who are male or female, aged 20 years or older.
  • People who have a specific type of cholesterol problem (mixed dyslipidemia) while already taking a moderate-strength statin medication — this includes certain doses of atorvastatin, rosuvastatin, simvastatin, pravastatin, lovastatin, fluvastatin, or pitavastatin (confirm with trial site for exact doses).
  • People whose cholesterol and fat levels meet specific thresholds: triglycerides at or above 200 mg/dL, HDL ("good") cholesterol at or below 50 mg/dL, and LDL ("bad") cholesterol at or above 100 mg/dL.
  • People who have been found to have a buildup (plaque) in the arteries of the neck, with a specific artery wall thickness measurement of 1.0 mm or more.
  • People who have no symptoms and no history of chest pain (angina), heart attack, or stroke.
  • People whose kidney function blood test (creatinine) is at or below 1.8 mg/dL.

Who may not be able to join

Each point below is a reason the trial team may not be able to accept someone. It is not a list of requirements to meet.

  • People with very high triglycerides (500 mg/dL or above) or very high LDL cholesterol (190 mg/dL or above) that would require a different type of treatment.
  • People with poorly controlled high blood pressure (systolic above 180 mmHg or diastolic above 110 mmHg).
  • People with severely reduced kidney function (eGFR below 30 mL/min/1.73m²).
  • People with significantly elevated liver enzyme levels or a chronic liver disease.
  • People who are pregnant, or people of childbearing potential who are not using adequate contraception.
  • People who have had changes made to their regular medications for chronic conditions (such as diabetes, high blood pressure, or cholesterol) within the past 3 months.
  • People who are currently taking cholesterol-lowering medications other than a statin.

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 30 July 2026
Phase 4 trials study a drug that has already been approved, monitoring long-term safety and effectiveness in real-world use.

Contact this trial

Phone: +82-31-787-7035

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Phase 4
Sponsor
Seoul National University Bundang Hospital
Registry
ClinicalTrials.gov
Start date
1 October 2022
Est. completion
31 December 2026

Where this trial is recruiting

🇰🇷 South Korea

Primary endpoints

Carotid intima media thickness

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 30 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov